# OnCo record chemotherapy-side-effects-colorectal (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/chemotherapy-side-effects-colorectal/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "chemotherapy-side-effects-colorectal" ;
  schema:name "Living with FOLFOX, CAPOX, FOLFIRI and the EGFR antibodies"@en ;
  schema:alternateName "FOLFOX side effects"@en, "CAPOX side effects"@en, "oxaliplatin cold sensitivity"@en, "irinotecan diarrhoea"@en, "cetuximab rash"@en, "DPD test"@en ;
  schema:description "The bowel cancer regimens share low blood counts, tiredness, sickness and a sore mouth. Oxaliplatin adds cold-triggered tingling, irinotecan adds early and late diarrhoea, capecitabine adds hand-foot syndrome and needs a DPD test first, and cetuximab or panitumumab add an acne-like rash and low magnesium. The rule for all of them: ring the 24-hour number rather than wait."@en ;
  schema:url <https://onco.cc/terms/chemotherapy-side-effects-colorectal/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/oxaliplatin>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/irinotecan>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/capecitabine>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/cetuximab>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/panitumumab>, <https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/folfox>, <https://www.bowelcanceruk.org.uk/about-bowel-cancer/living-with-and-beyond-bowel-cancer/long-term-and-late-side-effects/>, <https://www.nice.org.uk/guidance/ng151/chapter/Recommendations> ;
  onco:tag "gi", "colorectal" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/folfiri/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/irinotecan/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/panitumumab/> ;
  onco:terms <https://onco.cc/terms/peripheral-neuropathy/>, <https://onco.cc/terms/hand-foot-syndrome/>, <https://onco.cc/terms/rash-skin-toxicity/>, <https://onco.cc/terms/neutropenia/>, <https://onco.cc/terms/febrile-neutropenia/>, <https://onco.cc/terms/mucositis/> .